Albireo Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Albireo Pharma and buy or sell other stocks, ETFs, and their options commission-free!About ALBO
Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat.
CEORonald H. W. Cooper
CEORonald H. W. Cooper
Employees—
Employees—
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2003
Founded2003
Employees—
Employees—
ALBO Key Statistics
Market cap915.89M
Market cap915.89M
Price-Earnings ratio-6.57
Price-Earnings ratio-6.57
Dividend yield—
Dividend yield—
Average volume1.00M
Average volume1.00M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$45.23
52 Week high$45.23
52 Week low$16.02
52 Week low$16.02